Literature DB >> 31402180

A new device to improve target localization for transcranial magnetic stimulation therapy.

Nicholas T Trapp1, Brandt Uitermarkt2, Marcie King Johnson3, Timothy R Koscik4, Laren Garrett4, Amanda Heinzerling4, Mario Zanaty5, Marshall T Holland5, Matthew Howard5, Aaron D Boes6.   

Abstract

BACKGROUND: Accurate identification of cranial midline structures is essential for many targeting techniques that use repetitive transcranial magnetic stimulation (rTMS), including the Beam F3 method used for depression treatment.
OBJECTIVE: Evaluate whether a novel, laser-sighted device will assist with more accurate identification of the cranial midline relative to standard scalp-based measurement procedures.
METHODS: Three trained TMS technicians performed repeated scalp-based measurements to identify the inion and vertex on five subjects (n = 54 measurements). Measurements were compared to points identified with the midline localizer device and the true midline as defined by MRI midline structures.
RESULTS: Use of the midline localizer was more accurate for midline identification than technician measurement (p = 0.00025) and the ratio of localizing the midline within 5 mm was higher (78% versus 54%, p = 0.008).
CONCLUSION: Use of a laser-sighted midline localizer device can improve the accuracy of scalp measurements associated with target localization for rTMS treatment protocols.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  F3; Measurement; Midline; TMS; Targeting; Wishbone

Mesh:

Year:  2019        PMID: 31402180      PMCID: PMC7041559          DOI: 10.1016/j.brs.2019.07.028

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   8.955


  7 in total

1.  An efficient and accurate new method for locating the F3 position for prefrontal TMS applications.

Authors:  William Beam; Jeffrey J Borckardt; Scott T Reeves; Mark S George
Journal:  Brain Stimul       Date:  2009-01       Impact factor: 8.955

2.  Identification of reproducible individualized targets for treatment of depression with TMS based on intrinsic connectivity.

Authors:  Michael D Fox; Hesheng Liu; Alvaro Pascual-Leone
Journal:  Neuroimage       Date:  2012-11-07       Impact factor: 6.556

3.  Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial.

Authors:  Kevin A Johnson; Mirza Baig; Dave Ramsey; Sarah H Lisanby; David Avery; William M McDonald; Xingbao Li; Elisabeth R Bernhardt; David R Haynor; Paul E Holtzheimer; Harold A Sackeim; Mark S George; Ziad Nahas
Journal:  Brain Stimul       Date:  2012-03-14       Impact factor: 8.955

4.  Electric field depth-focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs.

Authors:  Zhi-De Deng; Sarah H Lisanby; Angel V Peterchev
Journal:  Brain Stimul       Date:  2012-03-21       Impact factor: 8.955

5.  Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial.

Authors:  Yechiel Levkovitz; Moshe Isserles; Frank Padberg; Sarah H Lisanby; Alexander Bystritsky; Guohua Xia; Aron Tendler; Zafiris J Daskalakis; Jaron L Winston; Pinhas Dannon; Hisham M Hafez; Irving M Reti; Oscar G Morales; Thomas E Schlaepfer; Eric Hollander; Joshua A Berman; Mustafa M Husain; Uzi Sofer; Ahava Stein; Shmulik Adler; Lisa Deutsch; Frederic Deutsch; Yiftach Roth; Mark S George; Abraham Zangen
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

Review 6.  The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder.

Authors:  Tarique Perera; Mark S George; Geoffrey Grammer; Philip G Janicak; Alvaro Pascual-Leone; Theodore S Wirecki
Journal:  Brain Stimul       Date:  2016-03-16       Impact factor: 8.955

7.  Concordance Between BeamF3 and MRI-neuronavigated Target Sites for Repetitive Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal Cortex.

Authors:  Arsalan Mir-Moghtadaei; Ruth Caballero; Peter Fried; Michael D Fox; Katherine Lee; Peter Giacobbe; Zafiris J Daskalakis; Daniel M Blumberger; Jonathan Downar
Journal:  Brain Stimul       Date:  2015-05-29       Impact factor: 8.955

  7 in total
  5 in total

1.  A landmark-based approach to locate symptom-specific transcranial magnetic stimulation targets of depression.

Authors:  Rongrong Du; Qian Zhou; Tianzheng Hu; Jinmei Sun; Qiang Hua; Yingru Wang; Yuanyuan Zhang; Kongliang He; Yanghua Tian; Gong-Jun Ji; Kai Wang
Journal:  Front Psychol       Date:  2022-09-02

2.  MEG-Derived Symptom-Sensitive Biomarkers with Long-Term Test-Retest Reliability.

Authors:  Don Krieger; Paul Shepard; Ryan Soose; Ava Puccio; Sue Beers; Walter Schneider; Anthony P Kontos; Michael W Collins; David O Okonkwo
Journal:  Diagnostics (Basel)       Date:  2021-12-30

3.  Effects of HF-rTMS over the left and right DLPFC on proactive and reactive cognitive control.

Authors:  Matias M Pulopulos; Jens Allaert; Marie-Anne Vanderhasselt; Alvaro Sanchez-Lopez; Sara De Witte; Chris Baeken; Rudi De Raedt
Journal:  Soc Cogn Affect Neurosci       Date:  2022-02-03       Impact factor: 3.436

4.  Symptom-Dependent Changes in MEG-Derived Neuroelectric Brain Activity in Traumatic Brain Injury Patients with Chronic Symptoms.

Authors:  Don Krieger; Paul Shepard; Ryan Soose; Ava M Puccio; Sue Beers; Walter Schneider; Anthony P Kontos; Michael W Collins; David O Okonkwo
Journal:  Med Sci (Basel)       Date:  2021-03-25

5.  The therapeutic effect of repetitive transcranial magnetic stimulation in elderly depression patients.

Authors:  Lilei Dai; Peng Wang; Panpan Zhang; Qingshan Guo; Hui Du; Fen Li; Xinfu He; Rongrong Luan
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.